| Ticker | MDGL |
|---|---|
| ISIN | US5588681057 |
| Sector | Atención sanitaria |
| Mercado | NASDAQ |
Madrigal Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapeutic candidates for the treatment of cardiovascular, metabolic, and liver diseases. Its lead product candidate is resmetirom, a liver-directed selective thyroid hormone receptor-ß agonist, which is in Phase III clinical trials for the treatment of non-alcoholic steatohepatitis. The company also develops MGL-3745, a backup compound to resmetirom. It has researc...
El precio actual de Madrigal Pharmaceuticals, Inc. (MDGL) es de 521,64 , con una variación del 1,81%.
Madrigal Pharmaceuticals, Inc. opera en el sector Healthcare, industria Biotechnology.
Compara brokers con acceso a las principales bolsas internacionales, con bajas comisiones, custodia y herramientas de análisis para invertir en acciones.
Compara brokers para acciones